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The acute effects of nifedipine (20 mg sublingually) on
hemodynamics and cardiac function were studied at rest
and during supine bicycle exercise in 20 patients with
aortic regurgitation. At rest, heart rate increased by
13%, systemicvascular resistance decreased by34% and
regurgitant index decreased by 17%. The change in sys-
temic vascular resistance was related to its initial rest
level (r =0.82, P < 0.001) and to the changes in forward
cardiac output (r =0.58, P < 0.01) and regurgitant index
(r =0.60, p < 0.01). Left ventricular end-diastolic and
end-systolic volumes, stroke volume and ejection frac-
tion were unchanged, whereas right ventricular ejection
fraction increased.
During exercise, nifedipine administration further in-
creased heart rate by 8% and decreased systemic vas-
Vasodilators may improve left ventricular function and clin-
ical functional class by reducing afterload in patients with
myocardial dysfunction (1-7). In patients with aortic re-
gurgitation, vasodilators have been shown to improve left
ventricular function and exercise capacity because they lower
arterial resistance (6-8).
Nifedipine is a potent arteriolar vasodilator. Its effects
on hemodynamics at rest in patients with aortic regurgitation
have recently been reported (8,9), but the effects during
exercise have not been well documented. The purpose of
this study was to investigate the acute effects of nifedipine
administration on both rest and exercise hemodynamics and
cardiac function in patients with chronic aortic regurgitation.
From Hallstrom Institute of Cardiology. University of Sydney and
Department of Nuclear Medicine, Royal Prince Alfred Hospital, Sydney,
Australia. Manuscript received March 7, 1984; revised manuscript received
May 30, 1984, accepted June 12, 1984,
Address for reprints: Professor David T. Kelly, Hallstrom Institute of
Cardiology, Royal Prince Alfred Hospital, Camperdown, New South Wales
2050, Australia.
© 1984 by the American Collegeof Cardiology
cular resistance by 19%. Both forward stroke volume
and forward cardiac output increased, but total left ven-
tricular stroke volume was unchanged, resulting in a
significant decrease in regurgitant index. Although left
ventricular end-diastolic volume was slightly decreased,
end-systolic volume did not increase; thus, ejection frac-
tion was higher than that during control exercise (p <
0.01).Right ventricular ejectionfraction increasedfurther.
In aortic regurgitation, the acute administration of
nifedipine improved cardiac performance and reduced
regurgitation at rest and during exercise as a result of
afterload reduction and increased heart rate. Whether
these beneficial effects will occur during long-term ther-
apy requires further investigation.
Methods
Study patients. Twenty patients (15 men and 5 women,
mean age 44 years) with at least moderately severe aortic
regurgitation, defined as pulse pressure greater than 55 mm
Hg, cardiomegaly on chest radiography and increased left
ventricular end-diastolic dimension on echocardiography,
were studied. Sixteen patients had cardiac catheterization
and greater than 2 + aortic regurgitation. Aortic regurgitation
was caused by rheumatic fever in 14 patients, congenital
abnormalities in 4 and cystic medionecrosis in 2. Three
patients were taking digitalis, 2 were taking diuretic drugs,
1 was taking a beta-adrenergic blocking agent and the re-
maining 14 had no medications. All patients had normal
sinus rhythm. Patients with acute aortic regurgitation, as-
sociated mitral valve disease, aortic stenosis or cardio-
myopathy were excluded on the basis of clinical history,
physical examinationand two-dimensional echocardiography.
In 14 patients without valvular regurgitation who had
undergone cardiac catheterization for assessment of coro-
nary artery disease, the radionuclide regurgitant index was
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measured at rest and during exercise before and after ni-
fedipine administration. Approval for the study was given
by the Institutional Ethics Committee.
Radionuclide determination of cardiac function.
Cardiac blood pool imaging was performed with the patient
in the supine position under a single crystal gamma camera
(Technicare Ohio, Sigma 420) fitted with a 30° slant hole,
high sensitivity collimator and interfaced to a digital com-
puter (PDP 11134). After in vivo labeling of red blood cells
with 20 to 25 mCi of technetium-99m using a standard
method (10-13), the camera was positioned in the 30 to
45° left anterior oblique projection. The caudal tilt of the
camera was adjusted carefully to clearly separate the atria
from the ventricles. Data were recorded in a 64 x 64matrix,
and the average cardiac cycle was divided into 24 frames.
Radionuclide data analysis was performed by a semiau-
tomatic edge detection program (11). We previously de-
scribed (12) the method for defining left ventricular region
of interest at end-diastole and end-systole. In our laboratory,
left ventricular ejection fraction measured by the radio-
nuclide method correlated well with that derived from con-
trast angiographic technique (11,12), and the nongeometric
radionuclide estimation of left ventricular volumes has been
validated (13) where the absolute left ventricular end-dia-
stolic volume == 2.94 x attenuated radionuclide left ven-
tricular end-diastolic volume + 2.3 ml (r = 0.98, SEE =
14 ml).
The right ventricular end-diastolic region was defined
on a simultaneously displayed original end-diastolic image
and stroke volume image and delineated by using a double
cursor technique. This region was used by the computer
program to search for a valid right ventricular end-diastolic
edge. The right ventricular end-systolic region was selected
on an end-systolic image displayed beside an end-systolic
binary edgemap. Using both images, the right ventricular
end-systolic region was drawn manually and used by the
computer program to search for a valid end-systolic region
of interest. The number of counts within end-diastolic and
end-systolic regions of interest was then determined. Right
ventricular ejection fraction was calculated by a standard
method (14). To determine the accuracy of this gated equi-
librium method of measuring right ventricular ejection frac-
tion, we performed first pass imaging in 19 patients before
gated equilibrium studies. The right ventricular ejection
fraction correlated well between the two methods (r = 0.95,
P < 0.001). Right ventricular stroke volume was determined
by a count-based technique (14). In our laboratory, the
radionuclide stroke volume correlated well with the ther-
modilution stroke volume: thermodilution stroke volume =
2.61 x radionuclide right ventricular stroke volume + 14
ml (r = 0.87, SEE = 8.6 rnl), and the changes in stroke
volumes measured by these two techniques were parallel in
direction and magnitude during graded exercise (unpub-
lished observations).
The regurgitant index was calculated as the ratio between
left and right ventricular stroke counts (15,16). The relation
between radionuclide regurgitant index at rest and angio-
graphic regurgitant fraction in 15 patients who had cardiac
catheterization within 1 week of radionuclide studies was
expressed as: radionuclide regurgitant index = 0.062 x
angiographic regurgitant fraction - 0.454 (r = 0.93, P <
0.001).
Study protocol. Patients performed supine bicycle ex-
ercise on an exercise table (Atomic Products) with the elec-
tronically braked ergometer (Siemens-Elerna) set at table
height. The initial work load of 15 W was increased pro-
gressively every 3 minutes by 15 or 30 W depending on the
patient's exercise tolerance. Exercise was limited by fatigue
or dyspnea, or both, in all patients with aortic regurgitation
and by angina in all patients without valvular regurgitation.
Radionuclide counts were collected for 6 minutes at rest
and during the last 2 minutes of each exercise level. A
peripheral venous blood sample was drawn immediately
after each imaging for determining blood count rate. Blood
pressure was measured with a standard sphygmomanometer
cuff by a single observer. Duplicate readings were made at
rest and at each level of exercise. Phase IV Korotkov sound
(muffling) was recorded as diastolic pressure. A CMs
electrocardiographic lead was monitored continuously and
a 12 lead electrocardiogram was recorded at rest and every
minuteduringexerciseon an AvionicsExerstress4000 system.
After control exercise, patients rested for 2 hours. Ni-
fedipine, 20 mg, was given sublingually. Twenty minutes
later, heart rate, blood pressure and gated blood pool im-
aging were repeated at rest and during exercise at work
loads identical to those of the control study.
The following calculations were performed: Rate-pres-
sure product = systolic blood pressure x heart rate. Mean
arterial pressure = D + (S - D)/3, where S = the systolic
blood pressure and D = the diastolic blood pressure. Sys-
temic vascular resistance (dynes-scm-5) =(MAP/CO) x 80,
where MAP = mean arterial pressure and CO = forward
cardiac output. Forward cardiac output = right ventricular
stroke volume x heart rate; total cardiac output = left
ventricular stroke volume x heart rate. Pressure-volume
ratio = systolic blood pressure/left ventricular end-systolic
volume; this was used as an indirect measure of myocardial
contractility (17,18).
Statistical analysis. Data were analyzed by two-way
analysis of variance. When there was a significant difference
between the four treatments (rest and exercise before and
after nifedipine administration), the treatment means were
compared using a modified t statistic incorporatingthe pooled
error mean square, with significance levels for four planned
comparisons derived from the Bonferroni two-tailed t table
(19). The relation between variables was tested using linear
regression analysis. Data are expressed as mean ± 1 stan-
dard deviation.
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Table 1. Effects of Nifedipine on Hemodynamics and Cardiac Function in 20 Patients With Aortic Regurgitation
Rest Exercise
Variable Before N After N Before N After N
HR (beats/min) 68 :t 10 77 :t 9* 117 ± 13+ 125 :t 16*+
MAP (mm Hg) 83 ± 7 75 ± 1* 108 ± 12+ 99 :t 13*+
RPP (x 100) 95 ± 22 94 ± 18 222 ± 44+ 233 :t 64+
RVSV (ml) 59 :t 13 71 ± 15* 74 :t 20+ 83 :t 19*+
RVea (liters/min) 4,1 ± 0.6 5.6 ± 1.1* 8.8 ± 2.U 10.8 :t 2.6*+
LVSV (ml) 139 :t 38 139 ± 36 131 :t 38 134 :t 31
Lvco (liters/min) 9.6 ± 3.3 10.9 ± 3.1 15.4 ± 4.0+ 17.4 ± 4.1*+
SVR (dynes·s-em- 5) 1695 ± 298 1114±168* 1030 ± 226+ 761 ± 201*+
LVEDV (ml) 242 ± 82 239 ± 81 256 ± 90 237 ± 83t
LVESV (m!) 103 :t 52 101 ± 54 126 ± 73+ 104 ± 61*
LVEF (%) 58 ± 8 60 ± 8 54 ± 12+ 60 ± 9*
PlY ratio I.5 :t 0.5 1.5 ± 0.6 1.9 ± 0.8+ 2.2 ± I.l+
RVEF (%) 46 :t 7 50 ± 8* 52 :t 12+ 59 :t 8*+
RI 2.4 :t 0.6 2.0 ± 0.4* 1.8 ± 0,3+ 1.6 ± 0.2*+
*p < 0.01, tp < 0.05, effects of nifedipine vs. corresponding control values (rest or exercise); :j:p < 0.01, effects of exercise vs. corresponding rest
values (before or after nifedipine therapy). HR = heart rate; LVea = total left ventricular output; LVEDV = left ventricular end-diastolic volume;
LVEF = left ventricular ejection fraction; LVESV = left ventricular end-systolic volume; LVSV = left ventricular stroke volume; MAP = mean
arterial pressure; N = nifedipine; PlY ratio = pressure-volume ratio; RI = regurgitant index; RPP = rate-pressure product; RVCa = right ventricular
forward cardiac output; RVEF = right ventricular ejection fraction; RVSV = right ventricular stroke volume; SVR = systemic vascular resistance.
Results
Patients without regurgitation. At rest, the mean re-
gurgitant index was close to unity (1.04 ± 0.12, range 0.90
to 1.26) and was unchanged after nifedipine. The regurgitant
index was not altered by exercise before (1.03 ± 0.07) and
after (1.04 ± 0.08) nifedipine.
Aortic regurgitation (Table 1). Rest. After nifedi-
pine, heart rate increased by 13% and mean arterial pressure
decreased by 9% because of a lower systolic pressure as
diastolic pressure was unchanged. The rate-pressure product
overall was unchanged. There was no change in total left
ventricular stroke volume; however, there was a 20% in-
crease in forward stroke volume and a 36% increase in
forward cardiac output associated with a significant decrease
in regurgitant index. Systemic vascular resistance decreased
by an average of 34% (Fig. 1). The change in systemic
vascular resistance was related to the initial level of systemic
vascular resistance (Fig. 2) and to the change in forward
cardiac output and regurgitant index (Fig. 3). Mean left
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Mean left ventricular end-diastolic volume was slightly
but significantly decreased from 256 ± 90 to 237 ± 83 ml
(p < 0.05) . The major difference was in the mean end-
systolic volume, which increased substantially during con-
trol exercise from 103 ± 52 ml at rest to 126 ± 73 ml
during exercise (p < 0.01), but was unchanged after nife-
dipine administration from 10I ± 54 ml at rest to 104 ±
61 ml during exercise (p = NS). Thus, ejection fraction
was higher than that during control exercise (Fig. 4). During
nifedipine exercise, the decrease in left ventricular end-
systolic volume was associated with a decrease in systolic
blood pressure; consequently, the pressure-volume ratio was
not significantly different. Right ventricular ejection fraction
increased further.
Figure 2. Relation between change s in systemic vascular resis-
tance (L.\SYR) and initial systemic vascular resistance at rest. Pa-
tients with high baseline systemic vascular resistance at rest ex-
hibited a large decrease in resistance after nifedipine administration.
D.S.CM- s = dynes-s-cm: ".
ventricular end-diastolic and end-systolic volumes, ejection
fraction and pressure-volume ratio did not change signifi-
cantly (Fig. 4). Right ventricular ejection fraction increased.
Exercise . After nifedipine , at an identical level of ex-
ercise , heart rate increased by 9% and mean arterial pressure
decreased by 8%, resulting in no change in rate-pressure
product. Mean forward stroke volume was increased by
12%, but mean total left ventricular stroke volume was
unchanged. As a consequence, total left ventricular output
increased by 16% and forward cardiac output increased by
23%, associated with a further decrease in regurgitant index.
Systemic vascular resistance decreased by an average of
19% (Fig. I) . Nifedipine tended to reduce systemic vascular
resistance more when it was higher initially during control
exercise (r = 0.65 , p < 0.01) .
o 600 1200 1800 2400
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Discussion
In this study, the average radionuclide regurgitant index
for patients without valvular regurgitation was close to unity
and was not changed by nifedipine or exercise. This agrees
with the findings of other studies (20).
Hemodynamic effects of nifedipine in aortic regur-
gitation. In patients with chronic aortic regurgitation , ni-
fedipine improved hemodynamics both at rest and during
exercise . Left ventricular volumes decreased and ejection
fraction improved, particularly during exercise. At rest, sys-
temic vascular resistance decreased by a mean of 34% with
nifedipine, which was greater than previously reported (8).
This decrease appeared to be related to the initial level , with
the higher levels showing the greatest decreases as has been
reported previously (6,8,9). Forward stroke volume was
increased significantly after nifedipine. The forward cardiac
output increased and regurgitant flow decreased most in
patients with an initially high baseline systemic vascular
resistance. The rate-pressure product did not change in our
study. In contrast, Fioretti et al. (8) found a 14% reduction
in rate-pressure product due to a larger decrease in systolic
blood pressure with the same dose of nifedipine. Their study
was invasive and the vasodilator effect of angiographic con-
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Il.SVR (D.S,CM-S)
Figure 3. Relation between changes in systemic
vascular resistance (L.\SYR) and changes in (A) for-
ward cardiac output (L.\FORWARD CO) and (B)
regurgitant index (L.\RI) after admin istration of ni-
fedipine at rest. Note that patients with a large change
in systemic vascular resistance had the greatest in-
crease in forward cardiac output and greatest de-
crease in regurgitant flow. D.S.CM-s
dynes-s-cm - 5•
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Figure 4. Left ventricular end-
diastolic volume (LVEDV), left
ventricular end-systolic volume
(LVESV) and left ventricular ejec-
tion fraction (LVEF) at rest and
duringexercisebefore(C) andafter
nifedipine (N) administration.
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trast agent may have predisposed their patients to a greater
hypotensive effect of nifedipine.
After nifedipine, left ventricular stroke volume and ejec-
tion fraction at rest remained unchanged, consistent with
the previous findings (8,9) that after nifedipine a similar left
ventricular performance is delivered at lower loading
conditions.
Improved ventricular performance and reduced re-
gurgitation after nifedipine. Although the response to ni-
fedipine in patients with aortic regurgitation has been studied
at rest (8,9), the changes during exercise are more important
in determining overall respon ses to the drug in ambulant
patients . The hemodynamic response to exercise in our pa-
tients before the administration of nifedipine confirmed pre-
vious findings (21,22) showing that although mean arterial
pressure increased, forward stroke volume and cardiac out-
put also increased and regurgitant flow decreased in asso-
ciation with an increase in heart rate and a reduction in
systemic vascular resistance.
In the present study, the average left ventricular end-
systolic volume significantly increased and left ventricular
ejection fraction decrea sed during exercise, suggesting that
the reduction in systemic vascular resistance induced by
exercise alone did not adequately compensate for the in-
creased hemodynamic burden on the left ventricle. The
administration of nifedipine produced a further decrease in
systemic vascular resistance in addition to that from vaso-
dilation of exercise. This was associated with a faster heart
rate , a lower mean arterial pressure and an increase in for-
ward stroke volume and cardiac output. Although left ven-
tricular end-diastolic volume was slightly decreased, nife-
dipine prevented the increa se in end-systolic volume seen
during control exercise, resulting in a higher left ventricular
ejection fraction, and indicated an improvement in left ven-
tricular performance. The pressure-volume ratio was not
significantly changed, suggesting that these effects were due
to changes in loading conditions. During exerci se after ni-
fedipine, the regurgitant flow was further decreased because
of lower systemic vascular resistance and a faster heart rate.
Clinical implications. Acute afterload reduction with
nifedipine improved hemodynamic status and cardiac per-
formance and reduced regurgitant flow at rest and during
exercise. The results of this short-term study suggest that
the effects of long-term afterload reduction with nifed ipine
in patients with chronic aortic regurgitation should be
investigated.
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References
1. Chatterjee K, Parmley WW, Massie S , et al. Oral hydralazine therapy
for chronic refractory heart failure. Circulation 1976;54:879- 83.
2. Massie S , Chatterjee K, Werner J, Greenberg S , Hart R, Parmley
WW. Hemodynamic advantage of combined administration of hy-
dralazine orally and nitrates nonparenterally in the vasodilator therapy
of chronic heart failure. Am 1 Cardiol 1977;40:794-801 .
3. Awan NA, Hermanovich J, Whitcomb C, Skinner P, Mason DT.
Cardiocirculatory effects of afterload reduction with oral trimazosin
in severe chronic congestive heart failure. Am 1Cardiol 1979;44:126-31 .
4. Franciosa l A , Cohn I N. Immediate effects of hydralazine- isosorbide
dinitra te combination on exercise capacity and exercise hemod ynamics
in patients with left ventricular failure. Circulation 1979;59:1085-91.
5. Bolen J l, ; Alderman EL. Hemodynamic consequences of afterload
reduction in patients with chronic aortic regurgitation . Circulation
1975;53:879-83.
6. Greenberg BH. DeMots H. Murphy E, Rahimtoola S. Beneficial ef-
fects of hydralazine on rest and exercise hemodynamics in patients
with chronic aortic insufficiency. Circulation 1980;62:49-55.
7. Miller RR, Vismara LA, DeMaria AN , Salel A, Mason DT. Afterload
lACC Vol. 4, No.5
November 1984:902-7
SHEN ET AL.
NIFEDIPINE IN AORTIC REGURGITATIOt\
907
reduction therapy with nitropru sside in severe aortic regurgitation:
improved cardiac performance and reduced regurgit ant volume . Am
J Cardiol 1976;38:564-7 .
8. Fioretti P, Benussi B, Scardi S, Klugmann S, Brower RW, Camerini
F. Afterload reduction with nifedipine in aortic insufficiency. Am J
Cardiol 1982;49:1728-32.
9. Fioretti P, Klugmann S, Camerini F. Acute hemodynamic effects of
nifedipine at rest and during stress in severe aortic regurgitation . Eur
Heart J 1983;4:110--6.
10. Bautovich G, Hunt F, Hancock C , McGrath P, Maddelena D. Stannous
tin dosage for technetium -99m blood labelling in vivo (abstr ). Aust
NZ J Med 1977;7:341.
II. Uren RF, Newman HN, Cormack J, Bernstein L, Allen L, Dyer L.
Geometric determination of left ventricular volume from gated blood-
pool studies using a slant-hole coll imator. Radiology 1983;147:541-5 .
12. Tan AT, Sadick N, Kelly DT, Harris PJ, Freedman SB, Bautovich
G. Verapamil in stable effort angina : effects on left ventricular function
evaluated with exercise radionuclide ventriculography . Am J Cardiol
1980;49:425-30.
13. Tokuyasu Y, Roubin G, Hutton B, Bautovich G, Kelly DT, Harris
PI. The reproducibility of serial measurement of cardiac output and
left ventricular volume by gated blood pool imaging (abstr). Aust NZ
J Med 1983;13:421.
14. Dehmer GJ , Firth BG, Hillis LD, Nicod P, Willerson JT, Lewis SE.
Nongeometric determination of right ventricular volumes from equi-
librium blood pool scans . Am J Cardiol 1982;49:78-84.
15. Rigo P, Alderson PO, Robertson RM, Backer LC , Wagner HN. Mea-
surement of aort ic and mitral regurgitation by gated cardiac blood pool
scans . Circulation 1979;60:306-12.
16. Sorensen SG, O'Rourke RA, Chaudhuri TK . Noninvasive quantitation
of valvular regurgitation by gated equilibrium radionuclide angiog-
raphy. Circulation 1980;62: 1089-98.
17. Slutsky R, Karliner J, Gerber K, et at. Peak systolic blood pres-
sure/end-systolic volume ratio: assessment at rest and during exercise
in normal subjects and in patients with coronary heart disease . Am J
Cardiol 1980;46:813-20 .
18. Schuler G, von Olshausen K, Schwarz F. et al. Noninvasive assess-
ment of myocardial contractility in asymptom atic patients with severe
aortic regurgitation and normal left ventricular ejection fraction at rest.
Am J Cardiol 1982;50:45-52.
19. Gill JL. Design and Analysis of Experiments in Animal and Medical
Sciences. vol. 3. Ames, IA: Iowa State Univer sity, 1982:72.
20. Parrish MD, Graham TP, Born ML, et al. Radionuclide stroke count
ratio for assessment of right and left ventricular volume overload in
children . Am J Cardiol 1983;51:261-4.
21. Peter CA , Jones RH. Cardiac response to exercise in patients with
chronic aortic regurgitation. Am Heart J 1982;104:85-91.
22. Steingart RM, Yee C, Weinstein L, Scheuer J. Radionuclide ventric-
ulographic study of adaptation s to exerci se in aortic regurgitation. Am
J Cardiol 1983;51:483-8 .
